Sigma Planning Corp’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,194
Closed -$260K 762
2015
Q4
$260K Sell
8,194
-470
-5% -$14.4K 0.04% 504
2015
Q3
$242K Buy
+8,664
New +$302K 0.04% 505

Other funds holding SBIO

Sigma Planning Corp's SBIO Position: Q1 2016 in Review

Sigma Planning Corp sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2016, closing a stake of 8,194 shares — an estimated $260K sold.

Sigma Planning Corp first reported a position in SBIO in Q3 2015 and held it in 2 quarters. The position peaked at $260K in Q4 2015. 23 funds tracked by Wall St. Rank hold SBIO as of Q1 2016.

  • Sigma Planning Corp reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2016 after selling out during the quarter.
  • Sigma Planning Corp sold 8,194 ALPS Medical Breakthroughs ETF shares in Q1 2016, an estimated $260K.
  • Sigma Planning Corp first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and held it in 2 quarters.
  • Sigma Planning Corp's ALPS Medical Breakthroughs ETF position peaked at $260K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2016.

Based on Sigma Planning Corp's 13F filing for Q1 2016, filed 18 Apr 2016.